Seroprevalence of human papillomavirus immunoglobulin G antibodies among women presenting at the reproductive health clinic of a university teaching hospital in Nigeria.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4028856)

Published in Int J Womens Health on May 13, 2014

Authors

M Aminu1, Jz Gwafan1, Hi Inabo1, Ao Oguntayo2, Ee Ella1, Ak Koledade2

Author Affiliations

1: Department of Microbiology, Faculty of Science, Ahmadu Bello University, Zaria, Nigeria.
2: Department of Obstetrics and Gynaecology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria.

Articles cited by this

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86

The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73

Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med (1998) 11.61

Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis (1994) 7.00

Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA (2001) 4.26

Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA (2001) 3.07

Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol (2009) 2.74

The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev (2003) 2.52

Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis (2005) 2.51

Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine (2006) 2.51

HPV testing in primary screening of older women. Br J Cancer (1999) 2.44

Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer (2004) 2.33

Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ (2003) 2.04

Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. Am J Public Health (2001) 1.93

WHIM syndrome: congenital immune deficiency disease. Curr Opin Hematol (2009) 1.85

Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res (2008) 1.73

Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis (2008) 1.72

Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change? Lancet (1988) 1.66

Parental Knowledge, Attitudes, and Behaviours towards Human Papillomavirus Vaccination for Their Children: A Systematic Review from 2001 to 2011. Obstet Gynecol Int (2011) 1.62

Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control (2009) 1.52

Further comments on cancer of the uterine cervix, smoking, and herpesvirus infection. Am J Epidemiol (1984) 1.47

The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay. Hum Vaccin (2011) 1.35

Attitudes to HPV vaccination among parents of children aged 12-15 years-a population-based survey in Sweden. Int J Cancer (2010) 1.32

Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J Clin Pathol (2005) 1.29

Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer (2008) 1.27

Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. Cancer Res (1987) 1.21

Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes. J Clin Microbiol (2001) 1.17

Prevention of cervix cancer. Crit Rev Oncol Hematol (2000) 1.17

Cervical dysplasia: association with sexual behavior, smoking, and oral contraceptive use? Am J Obstet Gynecol (1985) 1.17

Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol (2007) 1.16

Measuring serum antibody to human papillomavirus following infection or vaccination. Gynecol Oncol (2010) 1.06

Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women from a rural area of southern Mozambique. Infect Dis Obstet Gynecol (2010) 1.03

Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection. Scand J Infect Dis (2008) 0.98

Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology. Br J Cancer (1995) 0.97

Human papillomavirus 16 infection in adenocarcinoma of the cervix. Br J Cancer (2005) 0.96

Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infect Agent Cancer (2010) 0.96

WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4. Blood (2012) 0.96

Knowledge and attitudes towards cervical cancer and human papillomavirus: a Nigerian pilot study. Afr J Reprod Health (2010) 0.94

Chlamydia trachomatis and genital human papillomavirus infections in female university students in Honduras. Am J Trop Med Hyg (2005) 0.90

Are smoking and chlamydial infection risk factors for CIN? Different results after adjustment for HPV DNA and antibodies. Br J Cancer (2003) 0.88

Serologic detection of human papillomavirus-related anogenital disease: new opportunities and challenges. J Natl Cancer Inst (1995) 0.87

Pathways of cervical cancer screening among Chinese women. Int J Womens Health (2013) 0.86

Case records of the Massachusetts General Hospital. Case 10-2009. A 23-year-old woman with an abnormal Papanicolaou smear. N Engl J Med (2009) 0.85

HPV prevalence at enrollment and baseline results from the Carolina Women's Care Study, a longitudinal study of HPV persistence in women of college age. Int J Womens Health (2013) 0.85

Mothers' human papilloma virus knowledge and willingness to vaccinate their adolescent daughters in Lagos, Nigeria. Int J Womens Health (2013) 0.84

Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides. Virol J (2012) 0.83

Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. Sex Transm Infect (2004) 0.82

Dietary factors in women with dysplasia colli uteri associated with human papillomavirus infection. Nutr Cancer (1998) 0.79

Articles by these authors

Rotavirus infection in four states in north-western Nigeria. Niger J Med (2008) 0.76